Soluble interleukin-2 receptor levels in patients with malignant melanoma and renal cell cancer.


Soluble interleukin-2 receptor (sIL-2R) levels were measured in sera from 33 patients with metastatic malignant melanoma and 14 patients with metastatic or advanced renal cell cancer. Significantly elevated levels were found in both groups compared to 30 healthy controls. No correlation was found between the levels of sIL-2R and clinical parameters such as… (More)


  • Presentations referencing similar topics